BioSurMesh - Consortium for developing post-operative antiadhesion barrier meshes
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB |
| Funding from Vinnova | SEK 999 846 |
| Project duration | November 2025 - November 2026 |
| Status | Ongoing |
| Venture | Deepened international collaborations |
| Call | Deepened collaboration with USA, UK and Singapore within Health and Life Science |
Purpose and goal
The goal for this project is to build a well-rounded international consortium focused on a long-term project plan for developing antiadhesive barrier meshes. This consortium will focus on industrial and academic partners from Sweden, Singapore, and UK. From the proof-of-concept results, this will help us decide on the long-term commercialization strategy and a roadmap to obtain approval for clinical trials.
Expected effects and result
Expected outcomes and effects of the project involve the establishment of a novel interdisciplinary collaboration with a focus on developing medical devices from sustainable biobased polymers. Our starting point for this long-term consortium is a proof-of-concept antiadhesive barrier mesh. The anticipated outcomes include an efficient, scalable prototype, a strengthened consortium for long-term research, and a framework for navigating market, intellectual property, and regulatory pathways
Planned approach and implementation
The project is structured around key work packages aimed at a long-term strategy to address postoperative adhesions in patients. The project consists of four main work packages: WP 1 focuses on creating and testing a proof of concept (PoC). WP 2 aims to build consortium competencies, the roadmap for regulatory approval, and potential partnerships. WP 3 involves comprehensive market and intellectual property analysis. WP 4 is on project management.